What is the current value of the NSAIDs market and its growth outlook?

The market is valued at USD 24.11 billion in 2025 and is projected to hit USD 32.15 billion by 2030 at a 5.93% CAGR. Read More

Which region is growing fastest in the NSAIDs market?

Asia-Pacific is forecast to expand at 6.58% CAGR through 2030 due to wider insurance coverage, local manufacturing scale-ups, and strong OTC demand. Read More

Why are topical NSAIDs gaining popularity?

Topical gels and patches offer comparable pain relief with fewer GI and cardiovascular side effects, making them the preferred option for high-risk patients. Read More

How are patent expirations influencing NSAID prices?

Expired exclusivities invite generic competition, which presses down price points and shifts brand focus toward new delivery platforms or fixed-dose combinations. Read More

What role does e-commerce play in NSAID distribution?

Online pharmacies are growing at 6.64% CAGR as consumers prioritize convenience, transparent pricing, and home delivery, prompting retailers to adopt omnichannel models. Read More

Are NSAIDs replacing opioids in moderate pain management?

Yes, recent guidelines recommend NSAIDs as first-line therapy for many moderate pain conditions because they provide effective relief without addiction risk. Read More

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Companies

This report lists the top Non-steroidal Anti-Inflammatory Drugs (NSAIDs) companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) industry.